Liu J - Search Results

1

Targeted co-delivery of curcumin and erlotinib by MoS₂ nanosheets for the combination of synergetic chemotherapy and photothermal therapy of lung cancer.

Chen Z, Wei X, Zheng Y, Zhang Z, Gu W, Liao W, Zhang H, Wang X, Liu J, Li H, Xu W. Chen Z, et al. Among authors: liu j. J Nanobiotechnology. 2023 Sep 16;21(1):333. doi: 10.1186/s12951-023-02099-4. J Nanobiotechnology. 2023. PMID: 37717020 Free PMC article.

2

Functionalized MoS₂-erlotinib produces hyperthermia under NIR.

Zhang C, Zhang D, Liu J, Wang J, Lu Y, Zheng J, Li B, Jia L. Zhang C, et al. Among authors: liu j. J Nanobiotechnology. 2019 Jun 19;17(1):76. doi: 10.1186/s12951-019-0508-9. J Nanobiotechnology. 2019. PMID: 31217009 Free PMC article.

3

Redox/NIR dual-responsive MoS₂ for synergetic chemo-photothermal therapy of cancer.

Liu J, Li F, Zheng J, Li B, Zhang D, Jia L. Liu J, et al. J Nanobiotechnology. 2019 Jul 3;17(1):78. doi: 10.1186/s12951-019-0510-2. J Nanobiotechnology. 2019. PMID: 31269964 Free PMC article.

4

Hepatoma-targeting and reactive oxygen species-responsive chitosan-based polymeric micelles for delivery of celastrol.

Zhang X, Xu X, Wang X, Lin Y, Zheng Y, Xu W, Liu J, Xu W. Zhang X, et al. Among authors: liu j. Carbohydr Polym. 2023 Mar 1;303:120439. doi: 10.1016/j.carbpol.2022.120439. Epub 2022 Dec 10. Carbohydr Polym. 2023. PMID: 36657834

5

Aptamer-Conjugated Chitosan-Anchored Liposomal Complexes for Targeted Delivery of Erlotinib to EGFR-Mutated Lung Cancer Cells.

Li F, Mei H, Xie X, Zhang H, Liu J, Lv T, Nie H, Gao Y, Jia L. Li F, et al. Among authors: liu j. AAPS J. 2017 May;19(3):814-826. doi: 10.1208/s12248-017-0057-9. Epub 2017 Feb 23. AAPS J. 2017. PMID: 28233244

6

Randomized controlled clinical trial of polyethylene glycol recombinant human granulocyte colony-stimulating factor in the treatment of neutropenia after chemotherapy for breast cancer.

Huang W, Liu J, Zeng Y, Wu F, Li N, Chen K, Hong Y, Wang L, Zhen H, Lin L. Huang W, et al. Among authors: liu j. Cancer Chemother Pharmacol. 2018 Oct;82(4):607-613. doi: 10.1007/s00280-018-3639-z. Epub 2018 Jul 24. Cancer Chemother Pharmacol. 2018. PMID: 30043207 Clinical Trial.

7

Redox-responsive hyaluronic acid-functionalized graphene oxide nanosheets for targeted delivery of water-insoluble cancer drugs.

Liu J, Zhang D, Lian S, Zheng J, Li B, Li T, Jia L. Liu J, et al. Int J Nanomedicine. 2018 Nov 14;13:7457-7472. doi: 10.2147/IJN.S173889. eCollection 2018. Int J Nanomedicine. 2018. PMID: 30532533 Free PMC article.

8

Molybdenum disulfide-based hyaluronic acid-guided multifunctional theranostic nanoplatform for magnetic resonance imaging and synergetic chemo-photothermal therapy.

Liu J, Zheng J, Nie H, Zhang D, Cao D, Xing Z, Li B, Jia L. Liu J, et al. J Colloid Interface Sci. 2019 Jul 15;548:131-144. doi: 10.1016/j.jcis.2019.04.022. Epub 2019 Apr 8. J Colloid Interface Sci. 2019. PMID: 30991180

9

Co-delivery of sorafenib and metapristone encapsulated by CXCR4-targeted PLGA-PEG nanoparticles overcomes hepatocellular carcinoma resistance to sorafenib.

Zheng N, Liu W, Li B, Nie H, Liu J, Cheng Y, Wang J, Dong H, Jia L. Zheng N, et al. Among authors: liu j, liu w. J Exp Clin Cancer Res. 2019 May 31;38(1):232. doi: 10.1186/s13046-019-1216-x. J Exp Clin Cancer Res. 2019. PMID: 31151472 Free PMC article.

10

Tumor mutational burden in non-immunotherapy patients with heavily pretreated metastatic breast cancer: long-term outcomes from a single institution.

Wu F, Chen M, Li N, Wu X, Huang W, Chen X, Chen K, Wang L, Liu J. Wu F, et al. Among authors: liu j. J Chemother. 2023 Jul;35(4):348-356. doi: 10.1080/1120009X.2022.2107753. Epub 2022 Aug 24. J Chemother. 2023. PMID: 36000459

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

135,500 results

Search Page